235 related articles for article (PubMed ID: 33424228)
1. A Brief Overview of the Paradoxical Role of Glucocorticoids in Breast Cancer.
Zhidkova EM; Lylova ES; Savinkova AV; Mertsalov SA; Kirsanov KI; Belitsky GA; Yakubovskaya MG; Lesovaya EA
Breast Cancer (Auckl); 2020; 14():1178223420974667. PubMed ID: 33424228
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between NFkB and glucocorticoid signaling: a potential target of breast cancer therapy.
Ling J; Kumar R
Cancer Lett; 2012 Sep; 322(2):119-26. PubMed ID: 22433713
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid Receptor: A Multifaceted Actor in Breast Cancer.
Noureddine LM; Trédan O; Hussein N; Badran B; Le Romancer M; Poulard C
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923160
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid-dependent expression of IAP participates in the protection against TNF-mediated cytotoxicity in MCF7 cells.
Mitre-Aguilar IB; Barrios-Garcia T; Ruiz-Lopez VM; Cabrera-Quintero AJ; Mejia-Dominguez NR; Ventura-Gallegos JL; Moreno-Mitre D; Aranda-Gutierrez A; Mejia-Rangel J; Escalona-Guzman AR; Chavarri-Guerra Y; Leon-Del-Rio A; Zentella-Dehesa A
BMC Cancer; 2019 Apr; 19(1):356. PubMed ID: 30987626
[TBL] [Abstract][Full Text] [Related]
5. Boswellic acids and their derivatives as potent regulators of glucocorticoid receptor actions.
Karra AG; Tziortziou M; Kylindri P; Georgatza D; Gorgogietas VA; Makiou A; Krokida A; Tsialtas I; Kalousi FD; Papadopoulos GE; Papadopoulou KΚ; Psarra AG
Arch Biochem Biophys; 2020 Nov; 695():108656. PubMed ID: 33127380
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-708 activation by glucocorticoid receptor agonists regulate breast cancer tumorigenesis and metastasis via downregulation of NF-κB signaling.
Senthil Kumar KJ; Gokila Vani M; Hsieh HW; Lin CC; Liao JW; Chueh PJ; Wang SY
Carcinogenesis; 2019 Apr; 40(2):335-348. PubMed ID: 30726934
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid receptor and breast cancer.
Vilasco M; Communal L; Mourra N; Courtin A; Forgez P; Gompel A
Breast Cancer Res Treat; 2011 Nov; 130(1):1-10. PubMed ID: 21818591
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid-independent modulation of GR activity: Implications for immunotherapy.
Hapgood JP; Avenant C; Moliki JM
Pharmacol Ther; 2016 Sep; 165():93-113. PubMed ID: 27288728
[TBL] [Abstract][Full Text] [Related]
9. Roles of the Glucocorticoid and Mineralocorticoid Receptors in Skin Pathophysiology.
Sevilla LM; Pérez P
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966221
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid receptor action in beneficial and side effects of steroid therapy: lessons from conditional knockout mice.
Kleiman A; Tuckermann JP
Mol Cell Endocrinol; 2007 Sep; 275(1-2):98-108. PubMed ID: 17587493
[TBL] [Abstract][Full Text] [Related]
11. Significance of glucocorticoid signaling in triple-negative breast cancer patients: a newly revealed interaction with androgen signaling.
Kanai A; McNamara KM; Iwabuchi E; Miki Y; Onodera Y; Guestini F; Khalid F; Sagara Y; Ohi Y; Rai Y; Yamaguchi R; Tanaka M; Miyashita M; Ishida T; Sasano H
Breast Cancer Res Treat; 2020 Feb; 180(1):97-110. PubMed ID: 31989378
[TBL] [Abstract][Full Text] [Related]
12. Activation of NFkB is a novel mechanism of pro-survival activity of glucocorticoids in breast cancer cells.
Khan S; Lopez-Dee Z; Kumar R; Ling J
Cancer Lett; 2013 Aug; 337(1):90-5. PubMed ID: 23693080
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of Rho-associated kinase 1/2 by glucocorticoids promotes migration, invasion and metastasis of melanoma.
Huang GX; Wang Y; Su J; Zhou P; Li B; Yin LJ; Lu J
Cancer Lett; 2017 Dec; 410():1-11. PubMed ID: 28923399
[TBL] [Abstract][Full Text] [Related]
14. Differential Glucocorticoid-Dependent Regulation and Function of the ERRFI1 Gene in Triple-Negative Breast Cancer.
Mojica CAR; Ybañez WS; Olarte KCV; Poblete ABC; Bagamasbad PD
Endocrinology; 2020 Jul; 161(7):. PubMed ID: 32432675
[TBL] [Abstract][Full Text] [Related]
15. SEGRAs: a novel class of anti-inflammatory compounds.
Schäcke H; Hennekes H; Schottelius A; Jaroch S; Lehmann M; Schmees N; Rehwinkel H; Asadullah K
Ernst Schering Res Found Workshop; 2002; (40):357-71. PubMed ID: 12355726
[TBL] [Abstract][Full Text] [Related]
16. Genomic and non-genomic effects of glucocorticoids: implications for breast cancer.
Mitre-Aguilar IB; Cabrera-Quintero AJ; Zentella-Dehesa A
Int J Clin Exp Pathol; 2015; 8(1):1-10. PubMed ID: 25755688
[TBL] [Abstract][Full Text] [Related]
17. The HPA - Immune Axis and the Immunomodulatory Actions of Glucocorticoids in the Brain.
Bellavance MA; Rivest S
Front Immunol; 2014; 5():136. PubMed ID: 24744759
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cells.
Schlossmacher G; Stevens A; White A
J Endocrinol; 2011 Oct; 211(1):17-25. PubMed ID: 21602312
[TBL] [Abstract][Full Text] [Related]
19. A General Introduction to Glucocorticoid Biology.
Timmermans S; Souffriau J; Libert C
Front Immunol; 2019; 10():1545. PubMed ID: 31333672
[TBL] [Abstract][Full Text] [Related]
20. Targeting glucocorticoid side effects: selective glucocorticoid receptor modulator or glucocorticoid-induced leucine zipper? A perspective.
Ayroldi E; Macchiarulo A; Riccardi C
FASEB J; 2014 Dec; 28(12):5055-70. PubMed ID: 25205742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
